CLINICAL_TRIALS
trial_result
· 2011-08-19
Clinical Trial Update: Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Summary
A Phase 3 trial evaluated the efficacy and safety of different doses of indacaterol in chronic obstructive pulmonary disease, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2011-08-19